This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ketchum, P.A. Articles by AMCC SEPSIS Project Search for Related Content PubMed Articles by Ketchum, P.A. Articles by AMCC SEPSIS Project, Social Bookmarking                         What's this?

Utilization of a chromogenic Limulus amebocyte lysate blood assay in a multi-center study of sepsis

Associates of Cape Cod, Inc., Woods Hole, Massachusetts, USA

J. Parsonnet

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

L.S. Stotts

Associates of Cape Cod, Inc., Woods Hole, Massachusetts, USA

T.J. Novitsky

Associates of Cape Cod, Inc., Woods Hole, Massachusetts, USA

B. Schlain

Brian Schlain, Inc., Boston, Massachusetts, USA

D.W. Bates

Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

AMCC SEPSIS Project

Academic Medical Center Consortium, Rochester, New York, USA

We conducted a prospective study of a chromogenic LAL assay in 346 patients with sepsis syndrome, as defined by a modification of the Bone criteria, and 131 healthy volunteers at eight member centers of the Academic Medical College Consortium (AMCC). We identified patients with endotoxemia (> 0.40 EU/ml) by measuring LAL-reactive material in whole blood, extracted by the Tamura nitric acid method, with the chromogenic LAL (Pyrochrome®) assay. The mean result in sepsis patients with detectable endotoxemia (n = 241) was 1.07 ± 1.57 EU/ml, and the mean result in 131 volunteers was 0.151 ± 0.113 EU/ml, with 73% of the volunteers' results falling below the detectable limit. The average incidence of endotoxemia in sepsis patients was 33%, but varied 2.7-fold among the clinical centers (range 16-44%). Assay results were repeatable when samples tested frozen at the clinical sites were compared to results on frozen samples tested at Associates of Cape Cod, Inc. (ACC). Multiple samples were obtained from 40 patients at 18-24 h interval(s). Fourteen multidraw patients (35%) were endotoxemic at one or more draw(s) and eight of these patients had two or more draws with endotoxin levels > 1.0 EU/ml. The presence of sulfa drugs gave false positive results in two patient samples. A positive LAL test did not correlate with culture-proven bacterial infection and did not significantly correlate with mortality. There was a correlation (P = 0.014) between a patient having a positive LAL test and the presence of a fungal infection when mixed fungal and bacterial infections were included. There was no correlation with a positive LAL test when only a fungal infection was present (P = 0.425) or when only a fungal and a Gram-positive infection was present (P = 0.087).

Journal of Endotoxin Research, Vol. 4, No. 1, 9-16 (1997)
DOI: 10.1177/096805199700400102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. C. Hurley Diagnosis of Endotoxemia with Gram-Negative Bacteremia Is Bacterial Species Dependent: a Meta-Analysis of Clinical Studies J. Clin. Microbiol., December 1, 2009; 47(12): 3826 - 3831. [Abstract] [Full Text] [PDF]